150 research outputs found
PN-ISO 37001 management systems for anti-corruption actions and anti-corruption procedure in Jan Paweł II Hospital in Bełchatów
Report from the research: "The factory of culture – paid and voluntary work at cultural festivals"
The research material is based on in-depth, partially structured interviews. However, the scope of topics was very wide and conversations mostly referred to: problems that the employees encountered at work, their motivation, expectations towards current work, as well as their future prospects. Answers that gradually appeared in the interviews have been then confronted with the analysis of data and documents that the Ministry of Culture and National Heritage made available. Budgets of particular festivals and general data on their financial support have also been confronted with the interviews. Such an analysis gave us a stronger, structural base for conclusions made over the interpretation of interviews. One question that surprised us, but also showed us the benefits of the grounded theory, was the fact that data obtained from interviews mirrored the data from the documents. In total there were 48 interviews with the employees, co-workers and volunteers who worked at 12 festivals financed by the Ministry of Culture and National Heritage located in 6 different cities in Poland
Aktywność organów jednostek samorządu terytorialnego a ich dochody transferowe
The authors present a complex definition of the local authorities activity concept in connec-
tion with most common concepts of public finance: the decentralisation of public finance and the
decentralisation of local tasks. The authors emphasise the complexity of relations between these
concepts and the impact of this complexity of relations in the context of public finance crisis,
activities aiming at reduction of discrepancies between regions, etc. The article shows also the
need of detailed economic and law analysis and broad, professional discussions, taking into
account, as the starting point, the analogy between Poland and Spain
The presence and clinical implications of α-2,6-galactose-linked sialic acids in non-small-cell lung cancer brain metastases — preliminary study
Brain metastases (BM) in non-small-cell lung cancer (NSCLC) patients present an increasing clinical challenge. Identifying biomarkers which specifically identify patients at high risk of BM may improve their early diagnosis, which is crucial for surgical and radiotherapeutic treatment outcome. Alpha-2,6-sialyltransferase (α-2,6-ST) and the primary product of its activity, alpha-2,6-galactose-linked sialic acids (α-2,6-GalSA) have been found responsible for the adhesion of tumor cells to the brain vessels’ endothelium and enabling their transmigration through the blood-brain barrier in brain metastatic tumors. The aim of the study was to investigate by histochemical method the presence and possible role of α-2,6-GalSA in the formation of brain metastasis in NSCLC. In the screening phase 76 metastatic brain tumors were stained for α-2,6-GalSA and the second phase involved an identical staining of 20 primary tumors of patients who had their primary tumors treated with surgery or definite radiochemotherapy yet who later developed BM. The results were compared to a control group of 22 patients treated with surgery for NSCLC and who survived 5 years without the recurrence of disease. Alpha-2,6-GalSA presence was found to be down-regulated in poorly differentiated tumor types, whereas majority of differentiated tumors overexpressed it. This was statistically significant for both BM and the primary tumors. The expression of α-2,6-GalSA remained stable in primary and metastatic tumor pairs, however, no statistically significant differences were observed between study and control groups. Within the study group, a higher α-2,6-GalSA expression was associated with better overall survival, but not all statistical models found this result significant. Further studies are recommended to validate these findings
Use of Hydrothermal Carbonization and Cold Atmospheric Plasma for Surface Modification of Brewer’s Spent Grain and Activated Carbon
This paper presents results that show the effect of hydrothermal carbonization and subsequent cold plasma jet treatment with helium and argon on the structure and sorption properties of a material—spent brewery grain. Treatment of activated carbon, with a cold atmospheric plasma jet, was used comparatively. The effect of activation on the pore structure of the materials was carried out by the volumetric method at low pressure (N2, 77 K). The specific surface area as well as the total pore volume, average pore size, and pore size distribution were determined using different theoretical models. A high improvement in the sorption capacity parameter was obtained for hydrochars after cold atmospheric plasma jet treatment with an increase of 7.5 times (using He) and 11.6 times (using Ar) compared with hydrochars before cold atmospheric plasma jet treatment. The increase in specific surface area was five-fold (He) and fifteen-fold (Ar). For activated carbon, such a large change was not obtained after plasma activation. Regardless of the gas used, the increase in structural parameter values was 1.1–1.3
Topical formulations based on ursolic acid-loaded nanoemulgel with potential application in Psoriasis treatment
Psoriasis is a chronic disorder that causes a rash with itchy, scaly patches. It affects nearly 2–5% of the worldwide population and has a negative effect on patient quality of life. A variety of therapeutic approaches, e.g., glucocorticoid topical therapy, have shown limited efficacy with systemic adverse reactions. Therefore, novel therapeutic agents and physicochemical formulations are in constant need and should be obtained and tested in terms of effectiveness and minimization of side effects. For that reason, the aim of our study was to design and obtain various hybrid systems, nanoemulgel–macroemulsion and nanoemulgel–oleogel (bigel), as vehicles for ursolic acid (UA) and to verify their potential as topical formulations used in psoriasis treatment. Obtained topical formulations were characterized by conducting morphological, rheological, texture, and stability analysis. To determine the safety and effectiveness of the prepared ursolic acid carriers, in vitro studies on human keratinocyte cell-like HaCaT cells were performed with cytotoxicity analysis for individual components and each formulation. Moreover, a kinetic study of ursolic acid release from the obtained systems was conducted. All of the studied UA-loaded systems were well tolerated by keratinocyte cells and had suitable pH values and stability over time. The obtained formulations exhibit an apparent viscosity, ensuring the appropriate time of contact with the skin, ease of spreading, soft consistency, and adherence to the skin, which was confirmed by texture tests. The release of ursolic acid from each of the formulations is followed by a slow, controlled release according to the Korsmeyer–Peppas and Higuchi models. The elaborated systems could be considered suitable vehicles to deliver triterpene to psoriatic skin
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: Exploratory biomarker analyses of a randomized phase 3 trial
First-line nivolumab-plus-chemotherapy demonstrated superior overall survival (OS) and progression-free survival versus chemotherapy for advanced gastroesophageal adenocarcinoma with programmed death ligand 1 combined positive score ≥ 5, meeting both primary end points of the randomized phase 3 CheckMate 649 trial. Nivolumab-plus-ipilimumab provided durable responses and higher survival rates versus chemotherapy; however, the prespecified OS significance boundary was not met. To identify biomarkers predictive of differential efficacy outcomes, post hoc exploratory analyses were performed using whole-exome sequencing and RNA sequencing. Nivolumab-based therapies demonstrated improved efficacy versus chemotherapy in hypermutated and, to a lesser degree, Epstein–Barr virus-positive tumors compared with chromosomally unstable and genomically stable tumors. Within the KRAS-altered subgroup, only patients treated with nivolumab-plus-chemotherapy demonstrated improved OS benefit versus chemotherapy. Low stroma gene expression signature scores were associated with OS benefit with nivolumab-based regimens; high regulatory T cell signatures were associated with OS benefit only with nivolumab-plus-ipilimumab. Our analyses suggest that distinct and overlapping pathways contribute to the efficacy of nivolumab-based regimens in gastroesophageal adenocarcinoma
Polish consensus on gastric cancer diagnosis and treatment – update 2022
This document – “Polish consensus on gastric cancer diagnosis and treatment – update 2022” – represents an expert consensus following a year’s worth of dedicated effort by a team of specialists throughout 2021, put forward in a conference in December 2021 in Krakow, and finalized below for publication in 2022. The effective date of this document is June 14th 2022. The work that went into updating this consensus was made under auspices of the Polish Society of Surgical Oncology and the Association of Polish Surgeons
Polski konsensus diagnostyki i leczenia raka żołądka – aktualizacja 2022
This document – “Polish consensus on gastric cancer diagnosis and treatment – update 2022” – represents an expert consensus following a year’s worth of dedicated effort by a team of specialists throughout 2021, put forward in a conference in December 2021 in Krakow, and finalized below for publication in 2022. The effective date of this document is June 14th 2022. The work that went into updating this consensus was made under auspices of the Polish Society of Surgical Oncology and the Association of Polish Surgeons.Końcowy kształt niniejszego dokumentu – „Polski konsensus diagnostyki i leczenia raka żołądka – aktualizacja 2022” – jest wynikiem prac zespołu ekspertów, które prowadzone były w 2021 r., zwieńczone konferencją w grudniu 2021 r. w Krakowie i przygotowane w ostatecznej wersji do publikacji w roku 2022. Pracom nad aktualizacją konsensusu patronowały równorzędnie dwa towarzystwa naukowe: Polskie Towarzystwo Chirurgii Onkologicznej i Towarzystwo Chirurgów Polskich
Modeling and forecasting volatility. The use of daily prices in GARCH class models
Kokoszczyński, RyszardLink archiwalny https://depotuw.ceon.pl/handle/item/158
- …
